Kukreti R - Search Results

1

Genetic contribution of CYP1A1 variant on treatment outcome in epilepsy patients: a functional and interethnic perspective.

Talwar P, Kanojia N, Mahendru S, Baghel R, Grover S, Arora G, Grewal GK, Parween S, Srivastava A, Singh M, Vig S, Kushwaha S, Sharma S, Bala K; Indian Genome Variation Consortium; Kukreti S, Kukreti R. Talwar P, et al. Among authors: kukreti s, kukreti r. Pharmacogenomics J. 2017 Jun;17(3):242-251. doi: 10.1038/tpj.2016.1. Epub 2016 Mar 8. Pharmacogenomics J. 2017. PMID: 26951882

2

Hairpin-duplex equilibrium reflected in the A-->B transition in an undecamer quasi-palindrome present in the locus control region of the human beta-globin gene cluster.

Kaushik M, Kukreti R, Grover D, Brahmachari SK, Kukreti S. Kaushik M, et al. Among authors: kukreti s, kukreti r. Nucleic Acids Res. 2003 Dec 1;31(23):6904-15. doi: 10.1093/nar/gkg887. Nucleic Acids Res. 2003. PMID: 14627823 Free PMC article.

3

Beta(2)-adrenergic receptor polymorphisms and response to salbutamol among Indian asthmatics*.

Kukreti R, Bhatnagar P, B-Rao C, Gupta S, Madan B, Das C, Guleria R, Athavale AU, Brahmachari SK, Ghosh B. Kukreti R, et al. Pharmacogenomics. 2005 Jun;6(4):399-410. doi: 10.1517/14622416.6.4.399. Pharmacogenomics. 2005. PMID: 16004558

4

beta2-Adrenergic receptor polymorphisms and asthma in the North Indian population.

Bhatnagar P, Gupta S, Guleria R, Kukreti R. Bhatnagar P, et al. Among authors: kukreti r. Pharmacogenomics. 2005 Oct;6(7):713-9. doi: 10.2217/14622416.6.7.713. Pharmacogenomics. 2005. PMID: 16207148

5

Pharmacogenomics: a path to predictive medicine for schizophrenia.

Gupta S, Jain S, Brahmachari SK, Kukreti R. Gupta S, et al. Among authors: kukreti r. Pharmacogenomics. 2006 Jan;7(1):31-47. doi: 10.2217/14622416.7.1.31. Pharmacogenomics. 2006. PMID: 16354123 Review.

6

Pharmacogenomics of beta2-agonist: key focus on signaling pathways.

Bhatnagar P, Guleria R, Kukreti R. Bhatnagar P, et al. Among authors: kukreti r. Pharmacogenomics. 2006 Sep;7(6):919-33. doi: 10.2217/14622416.7.6.919. Pharmacogenomics. 2006. PMID: 16981850 Review.

7

Genetic landscape of the people of India: a canvas for disease gene exploration.

Indian Genome Variation Consortium. Indian Genome Variation Consortium. J Genet. 2008 Apr;87(1):3-20. doi: 10.1007/s12041-008-0002-x. J Genet. 2008. PMID: 18560169

8

Pharmacogenomics and treatment for dementia induced by Alzheimer's disease.

Gupta M, Kaur H, Grover S, Kukreti R. Gupta M, et al. Among authors: kukreti r. Pharmacogenomics. 2008 Jul;9(7):895-903. doi: 10.2217/14622416.9.7.895. Pharmacogenomics. 2008. PMID: 18597653 Review.

9

Genetic susceptibility to schizophrenia: role of dopaminergic pathway gene polymorphisms.

Gupta M, Chauhan C, Bhatnagar P, Gupta S, Grover S, Singh PK, Purushottam M, Mukherjee O, Jain S, Brahmachari SK, Kukreti R. Gupta M, et al. Among authors: kukreti r. Pharmacogenomics. 2009 Feb;10(2):277-91. doi: 10.2217/14622416.10.2.277. Pharmacogenomics. 2009. PMID: 19207030

10

Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment.

Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y, Chauhan C, Verma B, Manduva V, Mukherjee O, Purushottam M, Sharma A, Jain S, Brahmachari SK, Kukreti R. Gupta M, et al. Among authors: kukreti r. Pharmacogenomics. 2009 Mar;10(3):385-97. doi: 10.2217/14622416.10.3.385. Pharmacogenomics. 2009. PMID: 19290789

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters